Clinical Trials Logo

Pregnancy Related clinical trials

View clinical trials related to Pregnancy Related.

Filter by:

NCT ID: NCT05698407 Completed - Pregnancy Related Clinical Trials

Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia

Start date: March 16, 2023
Phase: Phase 4
Study type: Interventional

Sufentanil-ropivacaine combination is commonly used for epidural labor anesthesia, but is associated with some adverse events. Dexmedetomidine is a high selective alpha2-adrenoceptor agonist. Mounting evidences show that dexmedetomidine-ropivacaine combination can also be used effectively for epidural labor analgesia. This pilot trial is designed to compare the effect of dexmedetomidine-ropivacaine combination versus sufentanil-ropivacaine combination on neonatal outcomes when used for epidural labor analgesia, and to test the feasibility of a future large randomized trial.

NCT ID: NCT05687383 Completed - Pregnancy Related Clinical Trials

The Effect of Modified Pillow on Safety During Breastfeeding

Start date: April 11, 2023
Phase: N/A
Study type: Interventional

This study will investigate the effectiveness of a modified product "safe breastfeeding pillow" in enhancing the comfort and safety of postpartum women during breastfeeding. The results of this study can be used as a reference to promote clinical practice and education on breastfeeding to prolong the duration of breastfeeding and to ensure the safety of newborns.

NCT ID: NCT05684497 Completed - Low Back Pain Clinical Trials

THE EFFECTS OF PREVENTION PROGRAM ON LOW BACK PAIN AND QUALITY OF LIFE DURING PREGNANCY

Start date: July 9, 2021
Phase: N/A
Study type: Interventional

Although pregnancy is a natural process, it is a period in which some bio-physiological changes are experienced. These changes cause low back pain by affecting the musculoskeletal system as well as the endocrine, cardiovascular and renal systems. Pregnancy-related low back pain is defined as recurrent pain in the lumbopelvic region lasting more than one week. It can manifest itself in pregnancy as low back pain, lumbar pain, pelvic pain and lumbopelvic pain where both are present. In order to cope with low back pain in pregnancy and to increase the quality of life, low back pain should be evaluated in antenatal and postnatal follow-ups. Risk factors should be examined, women in the risk group should be identified, their low back pain experience should be questioned, prevention and coping strategies and the effect of low back pain on their quality of life should be evaluated. Healthy lifestyle programs should be developed to help prevent low back pain and develop coping strategies for pregnant women with low back pain.

NCT ID: NCT05679791 Completed - Pregnancy Related Clinical Trials

Comparative Study of Static and Dynamic Hand Grip Endurance in Pregnancy

Start date: February 15, 2022
Phase:
Study type: Observational

Background: Physiology of the mother, changes constantly during pregnancy including reduced HGS that is require for carrying the child after delivery. Activities of daily living require manual gripping tasks that require dynamic and static contractions. Predictor of upper extremity function is Hand Grip Strength and handgrip endurance. Screening of hand grip strength during antenatal care is still uncommon. Objectives: To compare static and dynamic hand grip endurance in pregnant females and to find its correlation with deep breathing. Material and Methods: The study recruited 40 participants of primi-gravida of 1st and 2nd trimester, between ages 20 and 35 years from SHALAMAR GYNAE OPD. The participants assigned to the groups (Group 1: with DB, Group 2: without DB) based on their trimester and gravidity. Static and dynamic endurance assessed using hand held dynamometer. Key words: Pregnancy, deep breathing, trimester, endurance, peak grip endurance

NCT ID: NCT05663762 Completed - Pregnancy Related Clinical Trials

How do Perceptions of Coronavirus Disease (COVID-19) Risk Influence Health Decisions in Pregnancy?

Start date: June 1, 2022
Phase:
Study type: Observational

Pregnant people have a higher risk of severe COVID-19 disease. Pregnant people have been disproportionately impacted by COVID-19 infection control policies, which have resulted in higher rates of intimate partner violence, mental health distress, employment and income loss. This project examines the impact of accumulated individual health decisions, describing how perinatal healthcare use and outcomes changed during the COVID-19 pandemic. Objectives, questions and hypotheses This research study has two objectives: 1. Describe differences between three groups of pregnant persons classified by the date they gave birth: 01/01/2019-03/31/2019 (2019 birth group), 01/01/2021-03/31/2021 (2021 birth group), and 01/01/2022-03/31/2022 (2022 birth group) pregnancy cohorts in Ontario and British Columbia relative to key outcomes and quality of care indicators related to vaccination, perinatal care, and mental health. Examine the differential impacts on racialized and low-income pregnant people. (Quantitative strand) 2. Understand how pregnant people's perceptions of COVID-19 risk and pandemic circumstances influenced their decision-making about key elements of pregnancy, including vaccination, perinatal care, social support and mental health. (Qualitative strand) Research questions and hypotheses have been operationalized according to our three themes: Theme 1: Vaccination Theme 2: Perinatal Care Theme 3: Mental Health and Social Support

NCT ID: NCT05634837 Completed - Pregnancy Related Clinical Trials

Increase in MedDiet Adherence in Pregnancy

Start date: May 31, 2019
Phase: N/A
Study type: Interventional

In the present randomised-controlled 3-month dietary intervention, we aim to a) increase Mediterranean diet adherence among apparently healthy pregnant women with the support of CDSS, and b) assess nutritional status and psychological parameters (anxiety and depression). To our knowledge, this is the first attempt investigating the effectiveness of CDSS in Mediterranean diet adherence of pregnant women.

NCT ID: NCT05626218 Completed - Anxiety Clinical Trials

Application of Stress Ball and Non-stress Test With Pregnant Women

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

This research was planned as a randomized controlled experimental study to reduce the anxiety expectant mothers feel when on a non-stress test.

NCT ID: NCT05552560 Completed - Pregnancy Related Clinical Trials

Access to Sperm Donation for Female Couples and Unmarried Women

PLEIAD
Start date: October 24, 2022
Phase:
Study type: Observational

The Bioethics Law of August 2, 2021 now authorizes, in addition to heterosexual couples, access to sperm donation for female couples and unmarried women. According to the Ministry of Health, since the opening of sperm donation to these new populations, requests at the national level (7000 during the first 6 months) have greatly exceeded the predicted figures (3000 per year). Welcoming this new patient population requires us, health professionals, to know it well. Indeed, to date, there is no reliable assessment in France of the life course, particularly reproductive, nor of the socio-demographic characteristics, nor of the psychological well-being of these patients. This study via a pseudonymised questionnaire aims to fill this lack of information in order to help professionals build relevant care pathways.

NCT ID: NCT05534867 Completed - Anxiety Clinical Trials

Effects of Mandala Coloring on Anxiety in Pregnant Women

Start date: November 11, 2022
Phase: N/A
Study type: Interventional

This research was planned as a randomized controlled experimental study in order to reduce the anxiety felt by expectant mothers in relation to pregnancy during pregnancy.

NCT ID: NCT05504889 Completed - Pregnancy Related Clinical Trials

Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum

CAMCAP
Start date: June 17, 2022
Phase:
Study type: Observational

This study addresses the second aim of the grant (R01 HD0899455), which is to determine temporal changes in CYP3A4-mediated drug metabolism sequentially across pregnancy and after birth.